Literature DB >> 27878471

Cerebrospinal fluid anti-Epstein-Barr virus specific oligoclonal IgM and IgG bands in patients with clinically isolated and Guillain-Barré syndrome.

Diana Ferraro1,2, Veronica Galli3, Anna Maria Simone4,5, Roberta Bedin3, Francesca Vitetta4, Elisa Merelli4, Paolo Frigio Nichelli4,5, Patrizia Sola4.   

Abstract

Epstein-Barr virus (EBV) has been implicated in multiple sclerosis (MS) pathogenesis. We aimed to assess the frequency of EBV-specific IgG and IgM oligoclonal bands (OCB) in cerebrospinal fluid (CSF) of 50 patients with clinically isolated syndrome (CIS) and in 27 controls with Guillain-Barré syndrome (GBS). Furthermore, we assessed correlations between the presence of OCB and CIS patients' CSF, MRI, and clinical variables. There was no difference in the proportion of CIS and GB patients with positivity for anti-EBV-specific IgG/IgM OCB. There were no correlations between OCB and analyzed variables, nor were they predictive of a higher disability at 3 years.

Entities:  

Keywords:  Clinically isolated syndrome; Epstein-Barr virus; Multiple sclerosis; Oligoclonal IgG bands; Oligoclonal IgM bands

Mesh:

Substances:

Year:  2016        PMID: 27878471     DOI: 10.1007/s13365-016-0493-9

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  23 in total

1.  The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands.

Authors:  I Boscá; M J Magraner; F Coret; J C Alvarez-Cermeño; M Simó-Castelló; L M Villar; B Casanova
Journal:  J Neuroimmunol       Date:  2010-06-09       Impact factor: 3.478

2.  Intrathecal immune responses to EBV in early MS.

Authors:  Emilie Jaquiéry; Samantha Jilek; Myriam Schluep; Pascal Meylan; Andreas Lysandropoulos; Giuseppe Pantaleo; Renaud A Du Pasquier
Journal:  Eur J Immunol       Date:  2010-03       Impact factor: 5.532

3.  Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation.

Authors:  Eduardo Beltrán; Birgit Obermeier; Markus Moser; Francisco Coret; María Simó-Castelló; Isabel Boscá; Francisco Pérez-Miralles; Luisa M Villar; Makbule Senel; Hayrettin Tumani; Reinhard Hohlfeld; Bonaventura Casanova; Klaus Dornmair
Journal:  Brain       Date:  2014-07-23       Impact factor: 13.501

4.  Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis.

Authors:  Diana Ferraro; Veronica Galli; Francesca Vitetta; Anna Maria Simone; Roberta Bedin; Cinzia Del Giovane; Franca Morselli; Maria Maddalena Filippini; Paolo Frigio Nichelli; Patrizia Sola
Journal:  J Neuroimmunol       Date:  2015-04-25       Impact factor: 3.478

5.  A sensitive and reproducible method for the detection of oligoclonal IgM bands.

Authors:  L M Villar; P González-Porqué; J Masjuán; J C Alvarez-Cermeño; A Bootello; G Keir
Journal:  J Immunol Methods       Date:  2001-12-01       Impact factor: 2.303

6.  Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis.

Authors:  Jan D Lünemann; Mar Tintoré; Brady Messmer; Till Strowig; Alex Rovira; Héctor Perkal; Estrella Caballero; Christian Münz; Xavier Montalban; Manuel Comabella
Journal:  Ann Neurol       Date:  2010-02       Impact factor: 10.422

7.  A functional and structural basis for TCR cross-reactivity in multiple sclerosis.

Authors:  Heather L E Lang; Helle Jacobsen; Shinji Ikemizu; Christina Andersson; Karl Harlos; Lars Madsen; Peter Hjorth; Leif Sondergaard; Arne Svejgaard; Kai Wucherpfennig; David I Stuart; John I Bell; E Yvonne Jones; Lars Fugger
Journal:  Nat Immunol       Date:  2002-09-03       Impact factor: 25.606

8.  Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.

Authors:  R A Farrell; D Antony; G R Wall; D A Clark; L Fisniku; J Swanton; Z Khaleeli; K Schmierer; D H Miller; G Giovannoni
Journal:  Neurology       Date:  2009-05-20       Impact factor: 9.910

9.  Influence of oligoclonal IgM specificity in multiple sclerosis disease course.

Authors:  Lm Villar; N García-Barragán; M Espiño; E Roldán; Mc Sádaba; J Gómez-Rial; P González-Porqué; Jc Alvarez-Cermeño
Journal:  Mult Scler       Date:  2007-10-17       Impact factor: 6.312

10.  Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.

Authors:  Massimiliano Castellazzi; Carlo Contini; Carmine Tamborino; Francesca Fasolo; Gloria Roversi; Silva Seraceni; Roberta Rizzo; Eleonora Baldi; Maria Rosaria Tola; Tiziana Bellini; Enrico Granieri; Enrico Fainardi
Journal:  J Neuroinflammation       Date:  2014-11-13       Impact factor: 8.322

View more
  1 in total

Review 1.  Neuromuscular Complications of SARS-CoV-2 and Other Viral Infections.

Authors:  Sarah Jacob; Ronak Kapadia; Tyler Soule; Honglin Luo; Kerri L Schellenberg; Renée N Douville; Gerald Pfeffer
Journal:  Front Neurol       Date:  2022-06-24       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.